NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Weimai

Weimai

Private
HangzhouHealthcare & Life Scienceshttps://myweimai.net/

Last Round

Series E

Sep 1, 2025

Est. Valuation

$708M

Total Funding Raised

$278.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Weimai is a digital healthcare solutions provider that offers an integrated platform for full-cycle disease management, connecting patients with public healthcare institutions and doctors through AI-driven services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical AI, Patient Engagement, InsurTech, NLP & Conversational AI

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital healthhealthcare managementtelemedicinemedical AIpatient engagementdigital therapeuticsDTxmanaged care organizationMCOinsurtechclinical workflow automationhealth techvirtual caredisease managementinsurance brokerage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Weimai Comparables

Compare Weimai with similar companies based on industry and business-model similarity.

Weimai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medlinker
80%
WeDoctor
79%
Beijing Yuanxin Technology Group Co., Ltd.
73%

Weimai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ESep 1, 2025
Series DJan 7, 2025
Series C ExtensionDec 14, 2020
Early FundingMay 1, 2020
Series CJun 20, 2019
Series B
Sep 13, 2018

Weimai Investors

Notable investors and investment history

Weimai investors
InvestorRounds
Yuanjing CapitalSeries D
IDG CapitalSeries C Extension, Series C
Yuanjing CapitalSeries B, Angel, Series D, Series A, Series C, Series C Extension
Cenova CapitalSeries B
MPCSeries B, Series C, Series A Extension, Series C Extension, Series A
Source Code CapitalSeries B, Angel, Series D, Series A, Series C, Series C Extension
千骥资本Series C, Series C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 224% MoM, reaching 31.3K.

  • May 1, 2025

    Monthly visitors increased 181% MoM, reaching 30.1K.

Weimai Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Weimai Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Weimai's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range46
Year Founded2013
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.